In May of 2025, the Patient-Centered Outcomes Research Institute awarded funding to a Duke Health program designed to implement electronic monitoring of patients’ self-reported symptoms during cancer treatment. AI Health Advisory Board Member Richard Shannon, who also serves as chief medical officer and chief quality officer for Duke Health, and Duke hematologist/oncologist Thomas LeBlanc, are leading the study.
